儿童及青少年非霍奇金淋巴瘤治疗后的第二恶性肿瘤——189例患者的回顾性多国研究
该回顾性多国研究纳入1980—2010年30年间来自欧洲儿童非霍奇金淋巴瘤协作组和/或柏林-法兰克福-明斯特研究组的189例儿童非霍奇金淋巴瘤后发生第二恶性肿瘤的患者,第二肿瘤分为髓系肿瘤、淋系肿瘤、癌、中枢神经系统肿瘤和其他五类;第二肿瘤诊断后5年总生存率为56±4%,合并基础疾病者最差为28±8%。
要点
- 第二肿瘤诊断后5年总生存率56±4%,合并基础疾病者仅28±8%。
- 髓系肿瘤和中枢神经系统肿瘤预后最差,5年总生存率分别为38±8%和34±12%。
- 癌和淋系肿瘤预后较好,5年总生存率分别为79±8%和59±7%。
核心结论
- 儿童非霍奇金淋巴瘤后发生第二肿瘤的患者中,合并癌症易感综合征(尤其是错配修复缺陷)者预后极差;癌和淋系肿瘤等部分亚型预后较好,而髓系肿瘤和中枢神经系统肿瘤预后黯淡。
研究设计与样本
- 回顾性多国研究,从欧洲儿童非霍奇金淋巴瘤协作组和/或柏林-法兰克福-明斯特研究组的19个成员单位检索1980—2010年30年间诊断为非霍奇金淋巴瘤后发生第二肿瘤的189例儿童及青少年患者。
主要发现
- 第二肿瘤分为5个亚组:髓系肿瘤43例(23%)、淋系肿瘤51例(27%)、癌48例(25%)、中枢神经系统肿瘤19例(10%)和其他28例(15%)。
- 37例(20%)报告有基础疾病,其中90%具有某种癌症易感综合征(CPS)。
- 189例原发非霍奇金淋巴瘤患者中,第二肿瘤诊断后5年总生存率(OS)为56±4%,合并基础疾病者最差为28±8%。
- 髓系肿瘤、淋系肿瘤、癌、中枢神经系统肿瘤和其他第二肿瘤的5年OS率分别为38±8%、59±7%、79±8%、34±12%和62±11%(p<0.0001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Data on the spectrum of second malignant neoplasms (SMNs) after primary childhood non-Hodgkin's lymphoma (NHL) are scarce. One-hundred-and-eighty-nine NHL patients diagnosed in a 30 years period of 1980-2010 developing an SMN were retrieved from 19 members of the European Intergroup for Childhood NHL and/or the international Berlin-Frankfurt-Münster Study Group. Five subgroups of SMNs were identified: (1) myeloid neoplasms (n = 43; 23%), (2) lymphoid neoplasms (n = 51; 27%), (3) carcinomas (n = 48; 25%), (4) central nervous system (CNS) tumors (n = 19; 10%), and (5) "other" SMNs (n = 28; 15%). In 37 patients (20%) preexisting disorders were reported with 90% having any kind of cancer predisposition syndrome (CPS). For the 189 primary NHL patients, 5-year overall survival (OS) after diagnosis of an SMN was 56 ± 4%, being worst for patients with preexisting disorders at 28 ± 8%. Five-year OS rates were 38 ± 8%, 59 ± 7%, 79 ± 8%, 34 ± 12%, and 62 ± 11%, respectively, for patients with myeloid and lymphoid neoplasms, carcinomas, CNS tumors, and "other" SMNs (p < 0.0001). Patients with SMNs after childhood NHL having a reported CPS, mostly mismatch repair disorders, carried a very poor prognosis. Moreover, although outcome was favorable in some subtypes of SMNs after childhood NHL (carcinomas, lymphoid neoplasms), other SMNs such as myeloid neoplasms and CNS tumors had a dismal prognosis.
引用
- Attarbaschi A, Carraro E, Ronceray L, et al. Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents. Leukemia. 2020. PMID: 32393843. doi:10.1038/s41375-020-0841-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。